Correlation Between Pharmadrug and Aion Therapeutic

Can any of the company-specific risk be diversified away by investing in both Pharmadrug and Aion Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmadrug and Aion Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmadrug and Aion Therapeutic, you can compare the effects of market volatilities on Pharmadrug and Aion Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmadrug with a short position of Aion Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmadrug and Aion Therapeutic.

Diversification Opportunities for Pharmadrug and Aion Therapeutic

-0.15

Correlation Coefficient

Pharmadrug  Aion Therapeutic

Good diversification

The 3 months correlation between Pharmadrug and Aion is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Pharmadrug and Aion Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aion Therapeutic and Pharmadrug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmadrug are associated (or correlated) with Aion Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aion Therapeutic has no effect on the direction of Pharmadrug i.e., Pharmadrug and Aion Therapeutic go up and down completely randomly.

Pair Corralation between Pharmadrug and Aion Therapeutic

Assuming the 90 days horizon Pharmadrug is expected to under-perform the Aion Therapeutic. But the pink sheet apears to be less risky and, when comparing its historical volatility, Pharmadrug is 2.31 times less risky than Aion Therapeutic. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Aion Therapeutic is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  0.58  in Aion Therapeutic on September 12, 2024 and sell it today you would lose (0.17) from holding Aion Therapeutic or give up 29.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pharmadrug  vs.  Aion Therapeutic

Pharmadrug

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmadrug are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Pharmadrug reported solid returns over the last few months and may actually be approaching a breakup point.

Aion Therapeutic

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aion Therapeutic are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, Aion Therapeutic reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pharmadrug and Aion Therapeutic

The main advantage of trading using opposite Pharmadrug and Aion Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmadrug position performs unexpectedly, Aion Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will offset losses from the drop in Aion Therapeutic's long position.

The idea behind Pharmadrug and Aion Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.